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INTRODUCTION 
Kidney stones are a common entity, affecting approximately 5% of  
women and 12% of  men in general population. 
Prevalence of kidney stone disease is increasing and likewise the 
complications associated with stone disease .The most life threatening 
being sepsis and renal failure.   Both could be treated with return of good 
renal function if managed early and meticulously. 
The pathophysiology of renal insufficiency in obstructive uropathy 
is well studied. 
Similar mechanism is seen in stone disease also.but specific 
feautures of calculous disease like duration of obstruction, type of 
stone,Infected system,location of stone plays an additional role along 
with obstruction. 
 Renal calculous disease may be associated with various degrees of 
renal insufficiency secondary to a combination of obstruction, urinary 
infection, frequent surgical intervention, and coexisting medical disease. 
Many patients with calculous disease  on conservative management  
by themself or by a nonspecialists land up in renal insufficiency due to 
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lack of timely referral to urologist and intervention.This type of 
presentation was seen in many patients .there are many queries about the 
recoverability of renal function in them if  renal parenchyma was thinned 
out. 
 In 25 patients with stone disease and elevated renal parameters we 
have studied the various factors influencing the outcome -preoperative, 
intraoperative,  postoperative. 
 We have analysed all the entities and the results after intervention 
in these patients.  
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AIM OF STUDY 
1. TO ANALYZE THE PREOPERATIVE FACTORS CAUSING 
RENAL INSUFFICIENCY  IN STONE DISEASE. 
2. TO ASSESS THE INTERVENTIONS DONE TO IMPROVE 
RENAL FUNCTION. 
3. TO DISCUSS THE FACTORS THAT DECIDE THE OUTCOME  
4. TO ANALYSE THE IMPROVEMENT IN RENAL FUNCTION 
AFTER INTERVENTION 
5. FOLLOW UP IN TREATED PATIENTS.  
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REVIEW OF LITERATURE 
 Urinary lithiases have been a major urological problem. A very 
high incidence was  reported in Pakistan, Northern India, Thailand, 
Afghanistan, Turkey, Egypt, Japan, Indonesia, Middle East, Europe, 
Netherlands and Scandinavian countries. Urolithiasis  constitutes  about 
10% to 25% of the total work load in the  urological practice.  In about 
5% of the patients  presenting with acute renal failure, the cause is  
obstructive uropathy and urolithiasis is the most common cause of 
obstruction. 
 Many patients with bilateral stones have oliguria .Calculus anuria 
is a urological emergency  due to bilateral ureteric calculus impaction  or 
unilateral ureteric calculus impaction of solitary  kidney or the only 
functioning kidney. After the onset of obstruction, there is increased 
intrapelvic pressure, resulting in   pyelolymphatic and pyelovenous urine 
back flow as  well as fornix rupture and urine extravasation.  
 Therefore, the obstruction of the urinary tract causes significant 
kidney damage. Prompt and early intervention can save the patient from 
developing irreversible renal damage. 
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 The patho physiological changes occurring in calculous obstruction 
is similar to the obstruction due to congenital obstructions which have 
been extensively studied.  
RENAL FUNCTIONAL CHANGES IN CALCULOUS 
OBSTRUCTION 
1)  GLOMERULAR FILTRATION 
 There are many functional changes in the kidney influenced by the 
extent and severity of obstruction, whether the obstruction is unilateral or 
bilateral, and whether the obstruction currently persists or has been 
relieved. 
 Obstruction can transiently or permanently alter GFR .After 
complete bilateral obstruction GFR is decreased but maintained due to  
 - Continuous salt and water absorption along nephron. 
- Ability of renal tract to dilate.  
- Alteration in renal hemodynamics. 
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2) RENAL BLOOD FLOW 
 There are differences between unilateral ureteral obstruction 
(UUO) and bilateral obstruction (BUO). 
 RBF was measured directly with various types of flow probes, and 
indirectly by measuring RPF using secretory markers and indexing this to 
hematocrit. 
 A number of vasoactive substances are thought to play a role in the 
changes in RBF and GFR. The varying hemodynamic patterns during the 
time course of obstruction may be due to a combination of vasoactive 
hormones synthesized and released at different rates, physical damage to 
glomerular and tubular units, and extrarenal compensatory mechanisms. 
Triphasic pattern of RBF and ureteral pressure changes.  
Unilateral Ureteral Obstruction- 
 1st phase-  1 to 2 hours – Vasoactive substances -prostaglandin E2 
(PGE2) & Nitric oxide (NO) produced causing Afferent arteriolar 
vasodilation- RBF increases inspite of  high tubular and collecting system 
pressure. 
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 2nd phase-  3 to 4 hours- pressure remain elevated but RBF begins 
to decline. 
 3rd phase-  5 hours- further decline in RBF,decrease in tubular and 
collecting system pressure shifts of blood flow from outer to inner cortex 
is seen. 
Bilateral Ureteral Occlusion  
 Modest increase in RBF due to Nitric oxide and platelet-activating 
factor- lasting 90 minutes. Followed by profound decrease in RBF –due 
to increased renal nerve stimulation - vasoconstriction related to 
increased renorenal reflex activity Endothelin,Angiotensin II and TXA2  
contribute to these responses. Blood flow showed a 92% decrease in inner 
medullary plasma flow. 
 3) Tubular pressure 
 Ureteral pressure is higher with BUO than with UUO.   
Both cases ureteral and tubular pressure is increased for the first 4 
to 5 hours, the ureteral pressure remains elevated for at least 24 hours 
with BUO, whereas it begins to decline and approaches preocclusion 
pressures by 24 hours with UUO.  
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 The prolonged elevation in intratubular pressure contributes to the 
profound decrease in SNGFR and whole kidney GFR.  Ureteral pressure 
remains high in BUO -Due to preglomerular vasodilation due to  Atrial 
natriuretic peptide (ANP)  and then a prolonged postglomerular 
vasoconstriction.  
 Post obstructive diuresis - Urine flow and sodium excretion are 
increased after release of BUO. ANP appears to play a prominent role in 
this response based on its natriuretic properties. 
4) Tubular Function   
Urinary Concentrating Abillity 
 Aquaporin 2 (AQP2) is present in the apical membranes of the 
collecting duct cells& Aquaporin 1 (AQP1),  in renal proximal tubules, 
the thin descending limb of Henle - promotes urinary concentration 
through the countercurrent multiplier by facilitating water transport from 
the descending limb of Henle into the interstitium . 
 The onset of concentration defects - 6 minutes of ureteral 
obstruction due to development of vasopressin resistance, Vascular 
changes -decrease in inner medullary plasma flow Necrosis of both the 
inner and outer medullae Release of obstruction resulted in polyuria that 
gradually decreased over a 30-day period. 
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Sodium Transport   
 Unilateral Ureteral Obstruction- increased fractional excretion of 
sodium (FENa) in the previously obstructed kidney due to contralateral 
kidney compensating for the sodium losses of its mate.  
 Bilateral Ureteral Obstruction-  The FENa may be increased to as 
much as 20 times normal in this setting due to ANP.  
 When the BUO is relieved, both intrarenal and extrarenal factors 
greatly enhance salt and water excretion. FENa following relief of BUO is 
typically greater than that after UUO because BUO causes retention of 
Na, water, urea nitrogen, and other osmolar substances and increased 
production of ANP, all of which stimulate a profound natriuresis.  
Potassium Transport  
 Decrease in K+ excretion due to reduced delivery of Na to the distal 
nephron, low volume flow rate that would minimize the transmembrane 
gradient for K+ secretion and  intrinsic defect in K+ secretion  
Hydrogen Ion Transport and Urinary Acidification  
Obstruction causes a deficit in urinary acidification. Major 
acidification defect is in the distal nephron due to defects in H+-ATPase 
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or H+,K+-ATPase, Cl-/HCO3- exchange, a back leak of protons into the 
renal interstitium 
Effects of Obstruction on ionTransport  
Phosphate –Rapidly excreted when BUO is released - 
Decrease in UUO.  
Magnesium -increased after the release of either UUO or BUO. 
Calcium -disruption of transport in areas of the nephron where Ca2+ and 
Mg2+ are differentially transported may account for varying effects of 
obstruction on their net transport and excretion. 
Effect of Obstruction on the Excretion of  Proteins  
 Proteins increased in urine-   Monocyte chemoattractant protein 1 
is a mediator of the inflammatory process  –is an index of tubular 
damage. Urinary enzymes from the proximal tubule - alkaline 
phosphatase, γ-glutamyltransferase, N-acetyl-β-D-glucosaminidase, and 
leucine aminopeptidas  are increased. 
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Proteins decreased in urine  -epidermal growth factor (EGF), 
Tamm-Horsfall protein  
Metabolic changes 
 Shift from oxidative metabolism to anaerobic respiration.  
Reduction of renal ATP levels, an increase in amounts of adenosine 
diphosphate (ADP) and adenosine monophosphate (AMP), and an 
increase in the renal lactate-to-pyruvate ratio. 
Chronic interstitial fibrosis  
 Tubulointerstitial fibrosis, tubular atrophy and apoptosis, and 
interstitial inflammation.Due to imbalance between Extracellular Matrix 
synthesis matrix deposition and matrix degradation. TGF-β, angiotensin 
II and tumor necrosis factor α (TNF-α) from the renal tubular and 
interstitial cells and  infiltrating macrophages -increase extracellular 
matrix synthesis and deposition. 
 Matrix metalloproteinases like collagenase  decrease and Tissue 
inhibitors of metalloproteinases Increase-  resulting in the accumulation 
of extracellular matrix. Infiltrating macrophages stimulate TGF-β 
synthesis, and  interleukin 2, interleukin 6, fibroblast growth factor, and 
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platelet-derived growth factor (PDGF) that appear to contribute to this 
inflammatory and fibrotic process.  
 Angiotensin II -upregulates the expression of TGF-β1 & TNF-α-
regulates vascular smooth muscles-neointimal thickening. Angiotensin II 
activates the transcription factor NFκB, which in turn increases the 
expression of several chemokines and cytokines involved with the 
fibrotic process. 
 Whereas UUO increased iNOS in the obstructed renal medulla and 
increased neuronal NOS (nNOS) and endothelial NOS (eNOS) in the 
cortex, losartan treatment downregulated iNOS and nNOS with 
unchanged levels of eNOS. Obstruction increases inducible, neuronal, 
and endothelial NOS and high concentrations of NO can result in 
peroxynitrite production- Administration of L-arginine by infusion or 
even by oral administration prevents the upregulation of iNOS, blunts the 
increase in renal interstitial volume, and attenuates the infiltration of the 
renal parenchyma by macrophages in rats with obstructed kidneys. 
 Bone morphogenic protein 7, a structural relative of TGF-β, was 
effective in preventing the tubulointerstitial changes and accelerating the 
return of renal function-this agent inhibited apoptosis.  
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 Hepatocyte growth factor  works by suppressing expression of 
TGF-β and PDGF. Pirfenidone- inhibits collagen synthesis, 
downregulates production of multiple cytokines and blocks fibroblast 
proliferation. 
Renal Recovery after Obstruction  
1) The duration of obstruction . 
• When acute- obstruction (3DAYS)is promptly relieved, full 
recovery of global GFR can occur.  
•  After 3 days of UUO, GFR and RBF were reduced to less than 
10% of their baseline values and Both returned to their baseline 
within 14 days of relief of obstruction   
• In  BUO in adults-two phases of functional improvement: initial 
phase -first 2 weeks -tubular function improved  
later phase -next 10 weeks –Glomerular function improved.  
2) Degree of obstruction-mild to moderare hydronephrosis cause 
parenchymal damage less than severe hydronephrosis.  
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3) Compliance of the collecting system-extrarenal pelvis is more 
compliant than intrarenal pelvis. 
4) Presence of pyelolymphatic backflow –reduces the renal pelvic 
pressure and also tubular pressure and subsequent renal damage.   
PATHOLOGIC CHANGES OF OBSTRUCTION  
Gross Pathologic Findings  
- Dilation of the pelvis and ureter and blunting of the papillary tips were 
present in the obstructed kidney at 42 hours after obstruction and the 
weight of this renal unit was heavier.  
- The cortex and medullary tissue in the obstructed kidney were 
diffusely thinned. 
Microscopic Pathologic Findings  
- lymphatic dilation, interstitial edema. 
 Collecting duct and tubular dilatation was prominent by 7 days.  
 Interstitial edema, widening of Bowman's space, tubular basement 
membrane thickening, Interstitial fibrosis and thickening of the tubular 
basement membrane  
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 Glomerular collapse and tubular atrophy, interstitial fibrosis, and 
proliferation of connective tissue in the collecting system were reported at 
5 to 6 weeks after obstruction. 
 Stone disease-a brief review of the types of stones and their 
pathophysiology. 
 Urinary tract stone disease  is likely caused by two basic 
phenomena. The first phenomenon is supersaturation of the urine by 
stone-forming constituents, including calcium, oxalate, and uric acid. 
Crystals or foreign bodies can act as nidi, upon which ions from the 
supersaturated urine form microscopic crystalline structures. The 
resulting calculi give rise to symptoms when they become impacted 
within the ureter as they pass toward the urinary bladder.  
 The overwhelming majority of renal calculi contain calcium. Uric 
acid calculi and crystals of uric acid, with or without other contaminating 
ions, comprise the bulk of the remaining minority. Other, less frequent 
stone types include cystine, ammonium acid urate, xanthine, 
dihydroxyadenine, and various rare stones related to precipitation of 
medications in the urinary tract. Supersaturation of the urine is likely the 
underlying cause of uric and cystine stones, but calcium-based stones 
(especially calcium oxalate stones) may have a more complex etiology.  
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 The second phenomenon, which is most likely responsible for 
calcium oxalate stones, is deposition of stone material on a renal papillary 
calcium phosphate nidus, typically a Randall plaque. 
 Calcium phosphate precipitates in the basement membrane of the 
thin loops of Henle, erodes into the interstitium, and then accumulates in 
the subepithelial space of the renal papilla. The subepithelial deposits, 
which have long been known as Randall plaques, eventually erode 
through the papillary urothelium. Stone matrix, calcium phosphate, and 
calcium oxalate gradually deposit on the substrate to create a urinary 
calculus.  
Stone Varieties 
A. Calcium Calculi 
 Eighty to eighty-five percent of all urinary stones are calcareous. 
Calcium nephrolithiasis is most commonly due to elevated urinary 
calcium, elevated urinary uric acid, elevated urinary oxalate, or a 
decreased level of urinary citrate. 
 Hypercalciuira is found as a solitary defect in 12% of patients and 
in combinationwith other defects in an additional 18%.  
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 Hyperuricosuria is identified as a solitary defect in 8% of patients 
and associated with additional defects in 16%. 
 Elevated urinary oxalate is found as a solitary finding in 5% of 
patients and as a combined defect in 16%. 
 Finally, decreased urinary citrate is found as an isolated defect in 
17% of patients and as a combined defect in an additional 10%. 
 Approximately one-third- no identiable metabolic defect. 
1. Absorptive hypercalciuric nephrolithiasis. 
 Normal calcium intake averages approximately 900-1000 mg/d. 
one-third is absorbed by the small bowel, and 150- 200 mg excreted in 
urine. Absorptive hypercalciuria is secondary to increased calcium 
absorption from the small bowel, predominantly from the jejunum. 
 This results in an increased load of calcium filtered from the 
glomerulus. The result is suppression of parathyroid hormone, leading to 
decreased tubular reabsorption of calcium, an increased absorption of 
calcium from the small bowel. 
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Absorptive hypercalciuria can be subdivided into 3 types.  
Type I absorptive hypercalciuria is independent of diet and  15% of all 
calcareous calculi.There is an elevated urinary calcium level (> 150-200 
mg/24 h) even during a calcium-restricted diet.  
 Treatment -Cellulose phosphate is an effective nonabsorbable 
exchange resin. This effectively binds the calcium in the gut, preventing 
bowel absorption. 
 Cellulose phosphate has no impact on the calcium transport defect. 
Urinary calcium excretion returns to normal values with therapy. 
 Cellulose phosphate must be taken with meals to be available when 
calcium is ingested. A typical dose is 10-15 g orally in 3 divided doses 
and is well tolerated. 
 Hydrochlorothiazides are an alternative treatment for type I 
absorptive hypercalciuria. 
Type II absorptive hypercalciuria is dietary dependent and is a common 
cause of urinary stone disease.  
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Treatment -There is no specific medical therapy. Calcium excretion 
returns to normal on a calcium-restricted diet. 
Patients should limit their calcium intake to 400-600 mg/d.  
Type III absorptive hypercalciuria is secondary to a phosphate renal leak 
and accounts for 5% of all urinary calculi. 
Decreased serum phosphate leads to an increase in 1,25-
dihydroxyvitamin D synthesis.  
Treatment - Orthophosphate - 250 mg 3-4 times daily. It is best 
taken after meals and before bedtime. Orthophosphates do not alter 
intestinal calcium absorption. 
2. Resorptive hypercalciuric nephrolithiasis-About half the patients 
with clinically obvious primary hyperparathyroidism present with 
nephrolithiasis. 
 This group represents less than 5-10% of all patients with urinary 
stones.  
 Hypercalcemia  is the most consistent sign of hyperparathyroidism. 
  20
 Surgical removal of the offending parathyroid  adenoma is the only 
effective way of treating this disease. Attempts at medical  management 
are futile. 
3. Renal  hypercalciuric nephrolithiasis—Hypercalciuria of renal origin 
is due to an intrinsic renal tubular defect in calcium excretion.  This 
creates a  physiologically vicious cycle. Excessive urinary calcium 
excretion - decrease serum calcium-secondarily increased parathyroid 
hormone - increases calcium  absorption from the gut. 
 These patients have an elevated fasting urinary calcium level, 
normal serum calcium level, and an elevated parathyroid hormone level. 
Renal hypercalciuria is effectively treated with 
hydrochlorothiazides. Stimulate proximal tubular absorption of calcium 
as well as other constituents. They also increase reabsorption at the distal 
tubule.  
4. Hyperuricosuric calcium nephrolithiasis—Hyperuricosuric calcium 
 Nephrolithiasis is due to either an excessive dietary intake of 
purines or an increase in endogenous uric acid production. In both 
situations there is an increase in urinary monosodium urates. 
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Monosodium urates absorb and adsorb urinary stone inhibitors  and 
facilitate heterogeneous nucleation. 
 Patients have elevated urinary uric acid levels (> 600 mg/24 h in 
women and > 750mg/24 h in men) and consistently have a urinary pH > 
5.5. The urinary pH helps to differentiate hyperuricosuric calcium from 
hyperuricosuric uric acid stone formation. 
 Patients with excessive purine intake can be effectively treated by 
changing their diet to one with low purines. Those with excessive 
endogenous uric acid production can be successfully treated with 
allopurinol. Allopurinol is a xanthine oxidase inhibitor. 
 Allopurinol reduces uric acid synthesis and renal excretion of uric 
acid. It also inhibits uric acid-calcium oxalate crystallization. 
  Allopurinol has many potential side effects- skin rashes and liver 
toxicity, and should be administered with careful monitoring (300 mg 
daily). Potassium citrate is an alternative treatment, especially when 
associated with hypocitraturia. 
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5. Hyperoxaluric calcium nephrolithiasis 
 Secondary to increased urinary oxalate levels (> 40 mg/24 h). 
found in  patients with inflammatory bowel disease or other chronic 
diarrheal states . It is rarely associated with excessive oxalate intake 
 Chronic diarrheal states alter oxalate metabolism. Malabsorption 
leads to increased luminal fat and bile. Intraluminal calcium readily binds 
to fat, resulting in a saponification process. Urinary calcium levels are 
usually low (< 100 mg/24 h). The intraluminal gut calcium that normally 
would have bound to oxalate is decreased. 
 The unbound oxalate is readily absorbed and is unaffected by the 
usual metabolic inhibitors of energy-dependent pumps. Bile salts may 
increase the passive bowel absorption of oxalate. 
  A small increase in oxalate absorption and subsequent urinary 
excretion dramatically increases the formation product of calcium-
oxalate. This increases the potential for heterogeneous nucleation and 
crystal growth in this metastable environment.  
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 Other factors-dehydration, hypocitraturia , decreased magnesium, 
and protein malabsorption. Enteric hyperoxaluric calcium nephrolithiasis 
is successfully treated with oral calcium supplementation. The calcium 
binds to the intraluminal oxalate and limits its absorption. It must be 
given with meals when the oxalate is present. Other oral cations are 
effective, including magnesium supplements. 
 Primary hyperoxaluria is a rare hereditary disease. It is associated 
with calcium oxalate renal calculi, nephrocalcinosis, and other distant 
deposits of oxalate, culminating in progressive renal failure and eventual 
death.  
Type I enzyme deficiency of alanine glyoxylate transaminase resulting in 
elevated urinary levels of glycolic acid and oxalic acid.  
Type II has increased excretory levels of L-glyceric acid rather than 
elevated levels of glycolic acid. It is associated with a D-glycerate 
dehydrogenase enzyme deficiency.  
 Combined liver and renal transplantation has cured this previously 
fatal rare disease. 
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6. Hypocitraturic calcium nephrolithiasis 
 Citrate is an important inhibitor of urinary stone disease. Increased 
metabolic demands on the mitochondria of renal cells decrease the 
excretion of citrate. Such conditions include intracellular metabolic 
acidosis, hypokalemia (as with thiazide therapy), fasting, 
hypomagnesemia, androgens, gluconeogenesis, and an acid-ash diet. 
Citrate may be consumed in the urine by bacteria during a urinary tract 
infection. The cause of hypocitraturia may be unknown in some cases. In 
contrast, alkalosis, alkaline-ash diet, estrogen, and vitamin D increase 
urinary citrate levels. 
 Citrate has its action in solution. It complexes with calcium, 
thereby decreasing the ionic calcium concentration and thus the activity 
product and thereby decreasing the energy for crystallization. Citrate 
decreases agglomeration, spontaneous nucleation, and crystal growth of 
calcium oxalate. Citrate also decreases calcium oxalate calculi by 
decreasing monosodium urates that can absorb inhibitors and facilitate 
heterogeneous nucleation. 
 Hypocitraturic (< 320 mg/24 h) calcium nephrolithiasis is 
associated commonly with renal tubular acidosis type I (distal tubule)  
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thiazide therapy (accompanied by potassium wastage), and chronic 
diarrhea.  
 Treatment - potassium citrate supplementation. Routine dosage is 
20-30 mEq 2-3 times daily and is usually well tolerated.  
B. Noncalcium Calculi 
1. Struvite—Struvite stones are composed of magnesium, ammonium, 
and phosphate (MAP). They are found most commonly in women and 
may recur rapidly.  
 They frequently present as renal staghorn calculi and rarely present 
as ureteral stones except after surgical intervention .   
 Struvite stones are infection stones associated with urea-splitting 
organisms-Proteus, Pseudomonas,  Providencia, Klebsiella, 
Staphylococci etc.  
 The high ammonium results in an alkaline urinary pH.below 7.2 
and MAP crystals precipitate.  
 MAP crystals are soluble in the normal urinary pH range of 5-7. 
 Foreign bodies and neurogenic bladders may predispose patients to 
urinary infections and subsequent struvite stone formation.  
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 Women with recurrent infections despite apparently appropriate 
antibiotic therapy should be evaluated for struvite calculi with a 
conventional kidney-ureter-bladder (KUB) film or renal ultrasound, or 
both. 
 Culture-specific antibiotics can  reduce urease levels by 99% and 
help reduce stone recurrence. Stone removal is therapeutic. 
 Long-term management is optimized with the removal of all 
foreign bodies, including  catheters of all varieties. A short ileal loop 
helps decrease the risk of stones in those with supravesical urinary 
diversion. All stone fragments should be removed with or without the aid 
of follow-up irrigations. Hemiacidrin (Renacidin) irrigations should be 
used with caution if at all.  
 Acetohydroxamic acid inhibits the action of bacterial urease, 
thereby reducing the urinary pH and decreasing the likelihood of 
precipitation.  
2. Uric acid—Uric acid stones compose less than 5% of all urinary 
calculi and are usually found in men. 
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 Patients with gout, myeloproliferative diseases, or rapid weight 
loss,malignant conditions with cytotoxic drugs . Most patients with uric 
acid calculi, however, do not have hyperuricemia. 
 Elevated uric acid levels are frequently due to dehydration and 
excessive purine intake. Patients present with a urinary pH consistently < 
5.5, in contrast to patients with hyperuricosuric calcium nephrolithiasis, 
who have a urinary pH > 5.5. As the urinary pH increases above the 
dissociation constant pKa of 5.75, it dissociates into a relatively soluble 
urate ion. 
 Treatment-urine volume > 2 L/d and a urinary pH > 6.0. Reducing 
dietary purines or the administration of allopurinol also helps reduce uric 
acid excretion. 
3. Cystine—Cystine lithiasis is secondary to an inborn error of 
metabolism resulting in abnormal intestinal (small bowel) mucosal 
absorption and renal tubular absorption of dibasic amino acids, including 
cystine, ornithine, lysine, and arginine.  
 They may present as single, multiple, or staghorn stones. Family 
history of urinary stones and the radiographic appearance of a faintly 
opaque, ground-glass, smooth-edged stone. Urinalysis- hexagonal 
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crystals. Stone analysis confirms the diagnosis. Quantitative urinary  
cystine - confirm the diagnosis Treatment -  
 Medical therapy includes high fluid intake (> 3 L/d) and urinary 
alkalinization.low-methionine (precursor to cystine) diet Penicillamine 
can reduce urinary cystine levels.  Mercaptopropionylglycine (Thiola), 
300-1200 mg in divided doses 
4. Xanthine—Xanthine stones are secondary to a congenital deficiency 
of xanthine oxidase. This enzyme normally catalyzes the oxidation of 
hypoxanthine to xanthine and of xanthine to uric acid. It is of interest that 
allopurinol, used to treat hyperuricosuric calcium nephrolithiasis and uric 
acid lithiasis, produces iatrogenic xanthinuria.  
 Blood and urine levels of uric acid are lowered, and hypoxanthine 
and xanthine levels are increased. Urinary stones develop in 25% of 
patients with a xanthine oxidase deficiency. The stones are radiolucent 
and are tannish-yellow in color.  
 Treatment- High fluid intake and urinary alkalinization are required 
for prophylaxis. If stones recur, a trial of allopurinol and a purine-
restricted diet is appropriate. 
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5. Indinavir—Protease inhibitors are a popular and effective treatment in 
patients with acquired immunodeficiency syndrome. Indinavir is the most 
common protease inhibitor that results in radiolucent stones in up to 6% 
of patients who are prescribed this medication. Indinavir calculi are the 
only urinary stones to be radiolucent on noncontrast CT scans.  
6. Rare—Silicate stones are very rare and are usually associated with  
long-term useof antacids containing silica. Surgical treatment is similar to 
that of other calculi. 
 Triamterene stones are radiolucent and have been identified with 
an increased frequency. They are associated with antihypertensive 
medications containing triamterene, such as Dyazide. Discontinuing the 
medication eliminates stone recurrences. Other medications - glafenine 
and antrafenine. 
Urolithiasis and renal failure 
 Urolithiasis is not a common cause of renal failure. Occur in 
bilateral stone with obstruction, solitary functional kidney,associated risk 
factors that cause renal injury. 
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Risk factors  
1) Diabetes Mellitus 
2) Hypertension 
3)  struvite staghorn calculi-increased risk of proteus 
infection,recurrence   of stone if not cleared,chances of 
complete obstruction. 
4) Urinary tract infections-urosepsis. 
5)  Percutaneous and extracorporeal urological methods -chronic 
deterioration of renal function if  treated with multiple 
therapeutic sessions.  
PREDICTORS OF RENAL FUNCTION IN UROLITHIASIS 
Preoperative  
 Duration of symptoms,Solitary functioning kidney,bilateral stone 
disease,Coexisting hypertension and diabetes,Stone burden,Atrophic 
renal cortex .,NSAID intake,functional or anatomical urological 
anomalies . 
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Intraoperative -Number of PCNL tracts, ESWL—sessions,  
Postoperative- Residual fragments, Recurrent infection Proteinuria, 
Recurrence of calculus 
Management of urolithiasis patients with obstruction and infection-  
Emergency settings  
•  Correct  dehydration. 
• Ranal function tests to assess renal function. 
•  Treat  urinary infections –start the patient on empirical third 
generation cephalopsporins. 
• Avoid using medications that may be detrimental to renal function. 
• Identifying patients with a solitary functional kidney,  
•  Reduce risks of acute renal failure from  contrast nephrotoxicity, 
particularly in patients with preexisting azotemia (creatinine >2 
mg/dL), diabetes, dehydration, or multiple myeloma 
•  Choosing imaging studies that do not require intravenous contrast 
(eg, ultrasound, abdominal flat plate radiographs, noncontrast CT 
scans) . 
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• Releive obstruction-PCN OR Double J stenting. 
• Definitive treatment-once sepsis settles.  
Function Assessment  
 SCr level is widely used as an index of renal fuction. Total 
creatinine clearance  exceeds the GFR because of tubular secretion, 
whereas the urea clearance is usually lower than the GFR because of 
tubular reabsorption. The mean of the creatinine and the urea clearance is 
a more accurate estimate of the GFR than either is separately. Factors 
associated with creatinine excretion (age, gender, ethnicity, tubular 
creatinine secretion and inhibition) may affect the accuracy of standard 
SCr measurements. The MDRD study equation to predict the GFR 
incorporates SCr concentration, demographic characteristics (age, gender, 
ethnicity), and other serum factors (urea, serum albumin). It is more 
accurate than other more widely used predictive equations or parameters  
 The MDRD equation for demographic and serum variables is: 
GFR = 170 × [PCr]-0.999 × [age]-0.176 × [0.762 if patient is female] × [1.180 
if patient is black] × [SUN]-0.170 × [Alb]-0.318  
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 Although the MDRD equation is better than other standard 
measures for GFR, it is inaccurate for patients not in a steady state for 
creatinine balance or those with a medical condition interfering with 
creatinine excretion or creatinine assay or both  
 Considering the current K/DOQI staging of renal function linked to 
level of GFR, a number of medical centers and commercial laboratories 
are using estimated GFR (eGFR) from SCr as a primary method of 
reporting kidney function because of inadequacies in SCr alone. The 
MDRD study equation is used most commonly to estimate GFR. The 
estimation of GFR from the MDRD study equation is not appropriate for 
patients who have rapidly changing kidney function, are at the extremes 
of age and body size, exhibit malnutrition or obesity, are paraplegic or 
quadriplegic, consume a vegetarian diet, or have diseases that have an 
impact on the skeletal muscle status. Moreover, in sick, hospitalized 
patients with moderately advanced renal failure, the Cockcroft-Gault, 
MDRD equations, and eGFR perform poorly when estimating GFR in 
this patient population and are not reliable measurements of RRF . In 
instances when the eGFR may not be accurate, a 24-hour urine collection 
for creatinine plus urea clearance divided by 2 is recommended. 
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Proteinuria  
 Increased excretion of albumin is a sensitive marker for renal 
damage attributable to diabetes mellitus, glomerular disease, interstitial 
disease, and hypertension.  In adults albuminuria can be identified by the 
use of albumin dipstick, urinary albumin concentration (UAC), 
albumin/creatinine ratio (ACR) measured in a spot morning urine sample, 
or urinary albumin excretion greater than or equal to 30 mg over 24 hours 
. Traditionally the cutoff value indicating a urinary albumin excretion 
greater than 30 mg/24 hr has been 3 mg/L . The standard urine protein 
dipstick is insensitive for low concentrations of albumin (<10 mg/dL) and 
for some immunoglobulin light chains. Dehydration, hematuria, exercise, 
infection, and extremely alkaline urine (pH > 8) can cause false-positive 
dipstick readings. 
Radiographic Assessment  
 The radiographic assessment should take into account the impact of 
contrast on renal function. Imaging techniques in CKD are usually 
utilized for investigation of new ARF or for investigation of potential 
problems in nonrenal sites (e.g., cardiac catheterization, peripheral 
vascular concerns, abdominal investigations). Contrast material can 
induce worsening of underlying renal disease to the point of requiring 
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RRT. All patients with abnormal SCr greater than 2 mg/dL should be 
considered for alternative diagnostic testing and prophylactic preventive 
strategies to avoid worsening renal function. Specific measures may help 
lower the risk for ARF in patients undergoing radiographic assessment. 
These include volume expansion, hydration with intravenous 
administration of normal saline solution (sodium chloride 0.9%), one-half 
strength saline solution (sodium chloride 0.45%), sodium bicarbonate 
solution, infusion of mannitol, administration of atrial natriuretic peptide, 
loop diuretics, calcium antagonists, theophylline, dopamine, N-
acetylcysteine, low-osmolar contrast, iso-osmolar contrast media, use of 
gadolinium-based contrast medium, CO2 angiography, hemodialysis 
shortly after contrast agent administration, and avoidance of short 
intervals between contrast studies 
 A number of reports have emphasized the value of normal saline 
solution hydration in patients  to generate a urine flow rate of 100 to  
150 mL/hr, thus decreasing the risk for contrast agent–induced 
nephropathy . Merely hydrating patients without ensuring effective urine 
flow is less valuable. There is no additional benefit to mannitol in the 
diabetic patient undergoing radiocontrast procedures; however, sodium 
bicarbonate solution infusion along with N-acetylcysteine may be of help. 
The antioxidant N-acetylcysteine (600 mg orally twice a day on the day 
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before and on the day of administration of the contrast agent) along with 
hydration using a 0.45% saline solution intravenously may decrease the 
risk of ARF from radiographic contrast agents in this patient group  
Measures to decrease renal deterioration  
 Regardless of the nature of the initial insult, once a critical number 
of nephrons is destroyed, a steady decline in GFR occurs as the 
progressive loss in viable nephrons occurs. And yet, it is becoming 
increasingly clear that well-designed renal assessment and management 
programs are feasible and can be systematically applied to large numbers 
of  patients to decrease the rate of progression before and after stone 
management. 
 International Society of Nephrology 2004 Consensus Workshop 
on Prevention of Progression of Renal Disease Lifestyle modifications, 
blood pressure control, glycemic control, reduction of proteinuria, protein 
restriction, lipid control, avoidance of nephrotoxic agents, early referral to 
a nephrologist, correction of anemia, optimization of calcium-phosphorus 
product, correction of acidosis, and maintenance of fluid balance. 
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 Various pharmacologic trials comparing different medications have 
shown that patients with better blood pressure control have significantly 
slower rates of deteriorating kidney function.  
 Angiotensin II is critical in causing progressive renal disease by 
both hemodynamic and nonhemodynamic mechanisms. Blockade of the 
renin-angiotensin system contributes to preservation of renal function by 
decreasing glomerular pressure and proteinuria. Because proteinuria plays 
a sentinel role in renal scarring, a reduction in proteinuria correlates with 
slowing of disease progression .  
 Clinical research findings support the view that preservation of 
renal function through angiotensin blockade can be achieved in patients 
with either diabetes mellitus or nondiabetic nephropathy. 
 Patients with diabetes mellitus and microalbuminuria were treated 
with ramipril   ACE inhibitors also prevent the slow decline in PO2 within 
the kidney. Considering the “hypoxia injury hypothesis,” a potentially 
important renoprotective mechanism of ACE inhibition could stem from 
this improvement in interstitial capillary PO2 levels, therefore decreasing 
the risk of renal sclerosis. 
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 Dietary modifications can reduce renal hyperfiltration injury. 
Formulations include  
 Low-protein (0.6 g protein/kg ideal body weight) diets, 
 Very low-protein diet (0.3 g protein/kg/day predominantly 
vegetable protein) supplemented with essential amino acids, 
 Very low-protein diet supplemented with both essential amino 
acids and nitrogen-free analogs of amino acids  
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MATERIALS AND METHODS 
 Study group: Patients who were admitted  in the Kilpauk Medical 
College Hospital and Govt. Royapettah hospital, Chennai , with  clinical 
diagnosis of urolithiasis from January 2009 – March 2011. 
1) Study design: cross sectional  study 
Inclusion criteria 
1) Patients with  stone disease.  
2) Increased renal parameters 
Exclusion criteria:  
1) Known case of medical renal disease. 
2) Patients with associated congenital anomalies of urinary tract 
causing obstruction. 
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sex 
male 
female
 Total number of patients included in the study are 25. 
 Among them 20 were male and 5 were female patients 
 
 
 
 
 
1)  AGE(yrs)           No 
20-30                  6 
31-40                  4 
41-50                  5 
51-60                  10 
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 Age distribution of the patients is  mainly middle age. 
 
 
 
 
 
 
 
2) DURATION OF SYMPTOMS 
 
 
 
 
 
 
 Most of the patients had vague loin pain . 4 patients presented with 
fever, chills, they are initially managed with systemic antibiotics before 
proceeding with further evaluation 
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3) URINE CULTURE 
After urine routine culture was done which showed  E.Coli growth 
in 3 patients and Proteus growth in 4 patients  Mixed growth was seen in 
2 patients Appropriate antibiotics were given according to the sensitivity. 
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4)  COMORBID ILLNESS 
 Patients history of medical,surgical illness is obtained. 
 Blood investigations – sugar ,urea, creatinine, electrolytes, Chest 
X-Ray PA view taken to find any pulmonary tuberculosis 
Blood pressure recorded 
Electrocardiogram taken in all patients 
 8 had Diabetes mellitus,out of which 3 patients had associated  
hypertension. 
 All the patients were evaluated for glycosylated hemoglobin and 
GTT done .Anti diabetic treatment and anti hypertensives were started   
2 had TB 
1 had Ischemic heart disease 
2 had Asthma 
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5) SERUM  CREATININE 
Creatinine is measured using jaffes method . 
Patients who are known cases of  medical renal disease are excluded from 
my study 
Base line creatinine of 1.5 mg% is taken as the criteria of renal 
insufficiency 
19 had creatinine 1.5-2.5,3 had 2.6-3.5,2 had 3.6-4.5,1 had 4.6-5.5 
Dialysis was done in the patient with creatinine 5mg% and operated  
craet555)555 
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6) PROTEINURIA 
Urine protein estimated since it represents the degree of renal 
damage and it correlates directly with the recoverability of renal function 
after surgery  
8 patients had 1+ proteinuria, 
4 Patients  had 2+ proteinuria. 
U 
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7) STONE LOCATION  
 All the patients were evaluated with USG and X-Ray KUBU. 
 Plain CT KUBU is taken in patients with irregularity in renal 
contour. 
 Kidney size, contour, degree of hydronephrosis, parenchymal 
thickness, internal echoes, perinephric collections, malignancy were 
assessed Size, location ,density of stone is assessed. 
 
 
 
 
 
 
 
STONE SIZE  
Ranged  from 1cm to 5.8cm 
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PARENCHYMAL THICKNESS 
Assessed by USG,CT-KUBU(Plain) 
17 patients had good parenchymal thickness 2 -2.5cm 
8 patients had reduced parenchymal thickness 
 
PA 
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Bilateral ureteric calculus with decreased cortical thickness 
METABOLIC EVALUATION- 
 Serum calcium,uric acid,PTH,electrolytes,urine ph,urine calcium 
was evaluated in all patients. 
Hypercalciruria is seen in 4 patients. 
PTH was normal in all patients. 
All the patients had normal electrolytes. 
 Urine ph is alkaline in 4 patients suggesting of infection by urease 
splitting organisms. 
 Stone analysis- out of 15 cases for which stone analysis was done 
five were struvite stones and rest of them calcium oxalate stones. 
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In four patients who presented with fever and pain initial PCN was 
done under USG Guidance  
 Turbid urine was  drained  and sent for urinalysis and culture and 
sensitivity.  
 In these patients open procedure was  undertaken after the infection 
settled. Open procedure was done in 7 patients  with renal stones.bilateral 
renal stones procedure was done on the symptomatic or better functioning 
side first followed by the other side after 3 months and there is no per 
operative difficulty in any of these patients.post operative X-Ray showed 
residual stones in the lower calyx in 2 cases for which ESWL was done. 
 ESWL is done in 3 patients with stone size 1cm after stenting.two 
patients had bilateral upper ureteric calculous obstruction.one patient had 
bilateral renal calculus for which stenting was done before 
ESWL.complete stone clearance was achieved .stent removal was done 
after 3 weeks. 
 PCNL was done in 2 patients.one was two staged procedure in 
which PCNL was undertaken after 2 weeks of PCN. 
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 Nephroscope with pneumatic lithotripsy was used and stones were 
fragmented,antegrade stenting was done, Ureteroscopy with pneumatic 
lithotripsy was done in  14 patients with  Good fragmentation was 
achieved and stenting was done. Ureterolithotomy was done in one 
patient with an impacted upper ureteric calculus, 
POST RIGHT PYELOLITHOTOMY WITH  LT URS WITH DJ 
STENT 
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POST OPERATIVE CREATININE 
 After a duration of two weeks the follow up creatinine gradually 
decreased and reached various nadir levels. 
Normal creatinine values  seen In 20 patients . 
1.2-1.5mg% in 3 patients, 
1.6 -2mg% achieved in 2 patients 
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POST OPERATIVE UTI 
 
 
 
 
 
 5 patients had post operative fever and urine culture in these 
patients showed E.Coli in 3 pts and proteus growth in 2 pts. All the 5 
patients settled on antibiotic treatment  
CORTICAL ATROPY 
 Post Obstructive atrophy changes were seen in 2 patients but renal 
function maintained in borderline. None of these needed dialysis support 
on follow up. 
PROTEINURIA 
 Proteinuria resolved in 10 patients .The other two had minimal 
proteinuria 
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STONE RECURRENCE 
All the patients on follow up of 2 yrs  
No stone recurrence was seen 
RESIDUAL FRAGMENTS – 
Seen in 3 patients and ESWL was done in two of these patients. 
Third patient is on follow up. 
STONE ANALYSIS – 
 5 stones were found to be struvite stones and  rest are calcium 
oxalate stones.  
 
 
 
 
                                                 
  55
RESULTS 
 Complete clearance defined as no visible fragment on KUB films 
and renal ultrasonography at 1 month follow-up   was achieved in 22 
patients (88%), while 3 patients (12%) had residual fragments. 
 Over a mean follow-up of 1 to 2 years , 1 patients showed evidence 
of recurrent calculi, and  5 patients had recurrent urinary tract infection.  
 Overall, 20 patients (80%) showed improvement, 5 patients (20 %) 
showed stabilization. 
 The baseline serum creatinine concentration correlated well with 
the postoperative renal function    which stabilized or improved in nearly 
all patients. 
DEMOGRAPHIC  DATA  
No. of patients  25 
Mean age (years) -40 yrs 
Sex (% male) 72% 
Side (% right) 53% 
Complete staghorn -3 
Partial staghorn -2 
Pelvic  -5 
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Mean calculus size -3cm 
Prior stone treatment -2 
Associated hypertension -3 
Associated diabetes -8 
Associated urinary infection -8 
Nephrostomy drainage required -4 
Dialysis required preoperatively -1 
Mean postoperative serum creatinine (mg/dL)-1mg% 
 
FACTORS EVALUATED  
Preoperative -Age ,Duration of symptoms,Coexisting hypertension and 
diabetes,Stone burden,Atrophic renal cortex  
Intraoperative-Procedure done  URS,ESWL,OPEN,PCNL. 
Postoperative- Creatinine, Residual fragments, Recurrent infection 
Proteinuria, Recurrence of calculus. Out of the 5 patients who had stable 
renal function but elevated serum creatinine 3 patients were diabetic with 
superimposed infection. 
Serum creatinine improved in them after  antibiotics .these patients 
are referred to nephrologist for further assessment and treatment to 
improve  renal function. 
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They were adviced to follow the protein and salt restricted diet  
ACE inhibitors were prescribed and the patients responded well to this 
treatment. 
 Strict follow up is adviced in both urology and nephrology 
departments.  2 patients in this group had dilated and thinned out 
parenchyma and post operative creatinine was higher than normal. 
 None of them required dialysis support in the follow up period of  
2 years. In patients with high base line serum creatinine post operative 
creatinine decreased only moderately depicting the glomerular injury that 
has occurred. In our study out of the various parameters studied Stone 
location rather than stone size was found to be an important factor since  
ureteral calculus in both kidneys or stone in solitary kidney were having  
high creatinine but good  post operative  improvement.  
 Choice of procedure does not seem to alter the outcome in these 
group of people.as per literature each PCNL procedure has a 1% loss of 
nephrons and each ESWL session has 2%-4% loss of nephrons.but with 
limited number of cases studied we are not able to comment on this 
aspect authentically.but for a large calculus where complete stone 
clearance is a must open procedure will minimize the loss of nephrons 
and also gives a better stone clearance. 
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  Large stag horn calculus if nonobstructing had good preserved 
renal function. Of the various factors Preop serum creatinine ,cortical 
thickness, diabetes mellitus, proteinuria, and recurrent  urinary infection 
were found to correlate with post operative   renal deterioration . 
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DISCUSSION 
 Few studies have addressed the problem of renal insufficiency in 
patients with urolithiasis (1–4). 
 Marengella and  coworkers (2) reported an 18% incidence of 
renal insufficiency in frequently relapsing idiopathic calcium stone 
formers.  
 Patients with renal calculous disease, particularly those with 
struvite staghorn calculi, are prone to renal damage because of various 
combinations of renal obstruction, infection, and surgical intervention. 
(1,3-5) 
 Calcium oxalate crystals are known to stimulate the proliferation of 
renal interstitial cells, thus triggering interstitial scarring (5). 
 Once chronic renal insufficiency is established, further progression 
has been attributed to hyperfiltration of the remaining functional 
nephrons (6). 
 Witherow and  Wickham(7)  in their studies suggested that long-
term renal function preservation  in patients with complex stone disease 
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depends on adequate blood pressure control, stone size, and stone 
clearance status. 
 They also reported that renal deterioration occurs more frequently 
in patients with stone disease in a solitary kidney (7). 
 Amanullah and associates (17)  in a study at Chandka Medical 
College, Larkana, Pakistan  found that   Out come of patients with 
calculus anuria is good, if   early diagnosis is made and prompt treatment 
should be given on emergency basis  
 Renal-specific mortality was 30% in the conservatively managed 
patients. Chandhoke and associates(11) found no significant 
deterioration in renal function in patients with mild or moderate renal 
insufficiency who underwent treatment for renal calculi with either SWL 
or PCNL. However, four of the five patients with creatinine values 3 
mg/dL showed deterioration. In a study of long-term renal function after 
staghorn calculus management -the renal cause-specific mortality was 0 
for patients with complete stone clearance (by PCNL, SWL, or 
combination therapy) and 67% in patients managed expectantly. 
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Renal functional outcome 
 In our study, the preoperative baseline serum creatinine  
concentration was an accurate predictor of postoperative renal  function 
deterioration: 
 100% of patients with serum creatinine  2.5 mg/dL, 96% of 
patients with creatinine between 2.5 and  3.5 mg/dL, and 40% of patients 
with serum creatinine between  3.5 and 5.5 mg/dL revealed stabilized or 
improved renal function  over a mean follow-up of1  years.  
 Our study revealed  atrophic renal parenchyma, large stone burden, 
diabetes mellitus,proteinuria  at follow-up, and recurrent urinary infection 
were  predictors of postoperative renal function deterioration  
Significant proteinuria and cortical atrophy indicate extensive 
glomerular and tubular functional loss(12,13). 
Patients with struvite calculi  develop renal function impairment 
because of obstructive  or pyelonephritic episodes(5). 
Aggressive treatment of obstruction and infection has been known 
to improve acute renal dysfunction. 
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Large stone burdens may be associated with a greater  degree of 
tubular obstruction, intrarenal interstitial fibrosis, and  
glomerulosclerosis, which may lead to nephron loss and a reduced  
glomerular filtration rate. 
Teichman and coworkers (10)  reported solitary kidneys to be  
more frequently associated with renal deterioration in patients   with 
staghorn calculi. 
  The safety of PCNL with respect to functional nephron loss is well 
established. (14,15) 
 SWL being reserved for  residual calculi. serum creatinine alone is 
not the ideal estimate of renal function.  
Creatinine clearance and renal scans may be more reliable in this 
regard.  
Few studies have addressed the problem of renal insufficiency in 
patients with nephrolithiasis. 
In a survey of 2000 patients by Gupta and associates,3 only 33 
patients (1.7%) experienced low to moderate grade renal insufficiency. 
In  our series 23 patients improved  after adequate relief of 
obstruction.  
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CONCLUSION 
 Most patients presenting with  renal insufficiency due to calculous 
disease  experience improvement or stabilization of renal function with  
early aggressive intervention aimed at complete stone clearance. 
Serum creatinine- was the most important predictor of renal 
recovery high baseline creatinine indicated severity of renal damage, post 
operative creatinine showed only moderate decrease in these patients. 
 Cortical atrophy –if associated with bilateral obstruction 
recoverability is moderate.even in unilateral cortical thinning opposite 
kidney goes for hyperfiltration injury and focal nephrosclerosis. 
 Renal preservative measures followed during this period helps in 
preventing hyperfiltration renal damage. 
 Diabetes mellitus- patients with DM  had more chances of 
progressing to renal insufficiency following calculous obstruction due to 
diabetic nephropathy with superimposed  resistant urinary tract 
infections.even in this group early intervention by diabetic 
control,infection control and stone removal showed good results 
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 Large stone burden- implied more fibrotic reaction .stag horn 
calculus were having preserved parenchyma due to lack of 
obstruction.Recurrent  or persistent urinary infection in these patients 
were associated with high incidence of  post operative renal deterioration. 
 Residual stones- Meticulous attention should be given towards 
stone clearance since residual stones can regrow, cause  obstruction, and 
urinary tract infection 
 Morbidity and mortality is reduced in these group of patients by 
judiciously handling the condition with timely interventions and further 
prevention of renal deterioration and follow up of these patients.  
 
         
                                             
 
S.
NO NAME AGE/SEX IP. NO  STONESIZE&LOCATION     CREATININE      U -C/S  U-PROTEIN
1 ARUN KUMAR 40/M 10034 B/L URETER-1CM 1.6 NG NIL
2 SELVAM 49/M 12429 LT.PELVIS-5CM 1.8 E.COLI 2+
3 SELVANATHAN 50Y/M 11307 LT.PELVIS-3.5CM 3.4 NG 1+
4 KRISHNAMOORTHY 30Y/M 961199 RT.PELVIC-1.5CM 1.9 E.COLI 1+
5 GOVINDARAJ 60/M 961299 LT URETER-1CM 1.9 PROTEUS 2+
6 GURUVAPPAN 50/M 12131 RT.RENAL -3.5CM 3.2 E.COLI 1+
7 DEVARAJ 50/M 2398 RT.RENAL -2CM 2 PROTEUS NIL
8 RAJENDRAN 48/M 28872 B/L URETER-1CM 1.5 NG NIL
9 SARAVANAN 41/M 30262 B/L URETER-1CM 2 NG NIL
10 KRISHNAN 24/M 9912 B/L STAGHORN 1.7 NG 1+
11 MANIKANDAN 31/M 9909 B/L URETER-0.8CM 2.8 E.COLI NIL
12 THIRUMALAI KUMAR 52/M 943284 B/L VUJ CALCULUS 1.8 NG NIL
13 MURUGAN 31/M 947722 B/L PELVIC CALCULUS 2 PROTEUS 1+
14 VENKATESH 70/M 942801 LT URETER-1CM 2.1 E.COLI 1+
15 MOHANAMBAL 41/F 942803 B/L VUJ CALCULUS 2 NG NIL
16 DURAI 56/M 941600 LT URETER-1CM 1.8 NG NIL
17 JAIRAM SINGH 36/M 970829 B/L URETER-1CM 2 NG NIL
18 DANIEL 44/M 969121 B/L URETER-1CM 3 NG 2+
19 HARIDASS 34/M 959068 B/LPELVIC-1.5CM 2 MIXED 1+
20 RANGANATHAN 48/M 957008 B/L URETER -1.5CM 2 NG NIL
21 ADITHYAN 18/M 967856 B/L URETER-1.5 CM 1.5 PROTEUS NIL
22 JULIET 41/F 930747 LT PELVIC -3 CM 5.5 PROTEUS 2+
23 MALLIKA 42/F 11232 B/L URETER-1.5 CM 1.6 NG NIL
24 MUNIAMMAL 60/F 921931 RT  URETER-2 CM 4.5 MIXED 1+
25 INDIRA 38/F 928713 B/L URETER -1.5CM 1.8 NG NIL
MASTER CHART
S.NO. NAME  COMORBID CORTEX  PROCEDURE
POST OP 
CREATININE UTI
1 ARUN KUMAR NIL 3CM B/L URS 0.8 NIL
2 SELVAM DM 2CM LTPYELOLITHOTOMY 1.5 NIL
3 SELVANATHAN DM/HT 2CM LTPYELOLITHOTOMY 1 NIL
4 KRISHNAMOORTHY NIL 2CM ESWL 0.8 NIL
5 GOVINDARAJ DM 1.3CM LT URS 1.4 E.COLI
6 GURUVAPPAN NIL 1.5CM RTPYELOLITHOTOMY 2 NIL
7 DEVARAJ DM/TB 2CM PCNL 1 NIL
8 RAJENDRAN NIL 2.5 CM B/L URS 1 NIL
9 SARAVANAN Asthma 2CM B/L URS 0.9 NIL
10 KRISHNAN NIL 2CM B/L PYELOLITHOTOMY 1 NIL
11 MANIKANDAN NIL 2.5CM B/L URS 1.2 NIL
12 THIRUMALAI KUMAR Asthma 3CM B/L URS 0.8 NIL
13 MURUGAN NIL 1.4CM RT OPEN /LT ESWL 1.4 PROTEUS
14 VENKATESH DM 1.5 CM ESWL 2 ECOLI
15 MOHANAMBAL NIL 2CM B/L URS 1 NIL
16 DURAI TB 2CM ESWL 1 NIL
17 JAIRAM SINGH NIL 2CM B/L URS 1 NIL
18 DANIEL DM/HT 2CM B/L URS 1 NIL
19 HARIDASS NIL 2CM PCNL 1 NIL
20 RANGANATHAN NIL 2CM B/L URS 1 NIL
21 ADITHYAN NIL 2.5CM B/L URS 0.7 NIL
22 JULIET DM/HT 1.3CM LT PYELOLITHOTOMY 1.8 ECOLI
23 MALLIKA NIL 3CM B/L URS 0.9 NIL
24 MUNIAMMAL DM 1.5CM RT URETEROLITHOTOMY 1.3 PROTEUS
25 INDIRA NIL 2.5CM B/L URS 1 NIL
LEFT STAG HORN CALCULUS 
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